Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma (FOCUS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02678572 |
Recruitment Status :
Active, not recruiting
First Posted : February 10, 2016
Last Update Posted : September 28, 2020
|
Sponsor:
Delcath Systems Inc.
Collaborator:
IQVIA Biotech
Information provided by (Responsible Party):
Delcath Systems Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | May 1, 2021 |
Estimated Study Completion Date : | July 15, 2021 |